Skip to content
★ Sign in to follow
HD

Hal Dietz

Board Director
GlaxoSmithKline plc
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 24 Jun 2022 for GlaxoSmithKline plc, €13k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Hal Dietz: trading record in brief

Hal Dietz appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). We count 2 filings; the first trade dates from 23 March 2022 and the latest from 23 June 2022.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 24 June 2022 with a share grant (€13k) in GlaxoSmithKline plc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Hal Dietz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    13,902 USD12FCA-NSM
    334.029 shares@ US$41.6251.2% of flowN/AISIN US37733W1053FCA-NSM:4417125-5
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    13,901 USD12FCA-NSM
    328.789 shares@ US$42.2848.8% of flowN/AISIN US37733W1053FCA-NSM:4313462-5

2 of 2 declarations